Male Androgenetic Alopecia

March 2014 in “ Turkderm ”

Zekayi Kutlubay, Süleyman Bağlam, Burhan Engin, Server Serdaroğlu

androgenetic alopecia AGA androgens anagen/telogen ratio topical minoxidil oral finasteride surgical methods 5% minoxidil solution 2% minoxidil solution 1 mg finasteride second-generation steroidal 5-alpha inhibitors hyperinsulinemia insulin resistance obesity Rogaine Propecia

From the encyclopedia

Minoxidil →

An essential vasodilator with some anti-androgenic effects

Finasteride →

Frontline, gold standard treatment for combatting androgenic alopecia

Studysummary This article reviews the causes, clinical features, and treatment options for androgenetic alopecia, but provides no new clinical findings.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on doi.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Male androgenetic alopecia: Population-based study in 1,005 subjects

41 citations , January 2009 in “International Journal of Trichology”

This study found that 58% of men aged 30-50 had androgenic alopecia, with disease severity increasing with age and many being candidates for medical treatment or hair transplantation.

research CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata

January 2024 in “International Journal of Molecular Sciences”

This study found that subcutaneous injection of a CXCL12 neutralizing antibody significantly promoted hair growth in androgenic alopecia and inhibited hair loss in alopecia areata in mouse models, suggesting its potential as a promising treatment for hair loss.

research HAIR LOSS AND REGENERATION PERFORMED ON ANIMAL MODELS

17 citations , October 2015 in “Medicine and Pharmacy Reports”

This article reviews current research on animal models for hair regrowth treatments and reports no new findings; it highlights the need for studies comparing therapy efficiency and long-term safety.

research The changes in the hair cycle during gestation and the post-partum period

34 citations , May 2013 in “Journal of the European Academy of Dermatology and Venereology”

In this study, changes in hair cycle phases during pregnancy and the post-partum period showed a rise in telogen rates after delivery, especially among non-breastfeeding women, but no drastic exaggerations were noted.

Investigating the Safety and Efficacy of Platelet-Rich Plasma Treatment for Female Androgenetic Alopecia: Review of the Literature

research Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature

8 citations , March 2021 in “Medicina-lithuania”

This review discusses the use of platelet-rich plasma for treating female androgenetic alopecia, reporting that it shows high patient satisfaction and improved quality of life in affected women.